About Piramal Enterprises Limited
Data last updated: 11 December 2025
Piramal Enterprises Limited was a public limited company based in Mumbai, Maharashtra, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It specialised in non-banking financial services (NBFC), a part of the broader financial services sector. Incorporated on 26 April 1947.
Registered with ROC Mumbai under CIN L24110MH1947PLC005719. Listed on BSE: 500302 and NSE: PEL.
Capital: an authorised share capital of ₹5,155 Cr and a paid-up capital of ₹45.34 Cr. Formerly known as Nicholas Piramal (India) Limited and Piramal Healthcare Limited. It was led by directors including Anand Ajay Piramal and Puneet Yadu Dalmia.
Last AGM: 30 June 2025. Financial statements filed for year ended 31 March 2025. Office: Piramal Ananta Agastya Corporate Park, Mumbai, Maharashtra.
As per NSE-filed consolidated financials for FY 2024, the company reported a revenue of ₹10,020 Cr, a growth of 12.16% compared to the previous year. The net worth stands at ₹26,557 Cr (down 14.5% YoY). Total assets are valued at ₹82,605 Cr (down 1.37% YoY).
The company had a reported workforce of approximately 241 employees prior to being dissolved. Its group structure included 19 subsidiaries.
The company was associated with 1 brand - Piramal Group. As per MCA filings, the company had open charges of ₹22,204 Cr and satisfied charges of ₹36,479 Cr on record.
The company has been merged (amalgamated) with another entity and no longer exists separately. Business activities, if any, continue under the successor entity. The last known website on record is piramal.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressPiramal Ananta Agastya Corporate Park Opp. Fire Brigade Kamani Junction Lbs Marg Kurl, A (West), Mumbai, Maharashtra, India – 400070
-
IndustryFinancial Services, NBFC
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Piramal Enterprises Limited
Piramal Enterprises Limited has undergone 4 name changes throughout its history. The current legal name is Piramal Enterprises Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Piramal Enterprises Limited | Current |
| Nicholas Piramal (India) Limited | Previous |
| Piramal Healthcare Limited | Previous |
| Indian Schering Pvt Ltd | Previous |
| Indian Schering Ltd | Previous |
CIN History of Piramal Enterprises Limited
Piramal Enterprises Limited has one previous CIN (Corporate Identification Number): U24110MH1947PLC005719. The current CIN is L24110MH1947PLC005719, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24110MH1947PLC005719 | Current |
| U24110MH1947PLC005719 | Previous |
Associated Brands with Piramal Enterprises Limited
Piramal Enterprises Limited operates one associated brand: Piramal Group. These brands represent Piramal Enterprises Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate | piramal.com |
Competitors & Alternatives of Piramal Enterprises Limited
Brands and companies operating in the same space as Piramal Enterprises Limited include Abzena, Syngene, Grand River Aseptic Manufacturing and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Abzena
|
Provider of antibody discovery, cell line development, and bio analytics services | Cambridge, United Kingdom, United Kingdom | 2001 |
Syngene
|
Provider of contract research and manufacturing services for both small molecules and biologics | Bengaluru, India, India | 1993 |
Grand River Aseptic Manufacturing
|
Sterile parenteral CDMO services for development and manufacturing are offered. | Grand Rapids, United States, United States | 2010 |
Patheon
|
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry | Durham, United States, United States | 1974 |
Panacea Biotec
|
Developer of biosimilars, vaccines and natural products | Ambala, India, India | 1984 |
Maravai Life Sciences
|
Provides enabling tools and services in the life sciences research and bio-production industries | San Diego, United States, United States | 2014 |
LakePharma
|
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering | Belmont, United States, United States | 2009 |
Insud Pharma
|
Finished formulations, APIs, and monoclonal antibodies are developed and manufactured. | Madrid, Spain, Spain | 1977 |
Business Activity of Piramal Enterprises Limited
Piramal Enterprises Limited is engaged in principal business activities including manufacturing and financial and insurance service, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, other financial activities. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| K | Financial and insurance Service | K8 | Other financial activities | Locked |
Business activity turnover details for Piramal Enterprises Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Piramal Enterprises Limited
Piramal Enterprises Limited is audited by DELOITTE HASKINS & SELLS LLP for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DELOITTE HASKINS & SELLS LLP | Locked | Locked | Locked |
Complete auditor history for Piramal Enterprises Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Piramal Enterprises Limited
Piramal Enterprises Limited currently reports 14 directors and 2 key managerial personnel. 20 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Ajay Piramal | Director | 12 May 2017 | 9 Years 2 Months | As last reported |
| Puneet Yadu Dalmia | Director | 07 Oct 2021 | 4 Years 9 Months | As last reported |
| Anjali Bansal | Director | 19 Nov 2020 | 5 Years 8 Months | As last reported |
|
Rajiv Mehrishi
Also directs:
Piramal Finance Limited, The Tata Power Company Limited, Dabur India Limited and 4 more
|
Director | 26 May 2022 | 4 Years 2 Months | As last reported |
|
Gautam Bhailal Doshi
Also directs:
Bhavna Doshi Associates Llp, Sun Pharmaceutical Industries Limited, Piramal Finance Limited and 5 more
|
Director | 31 Oct 2022 | 3 Years 8 Months | As last reported |
|
Kunal Bahl
Also directs:
Piramal Finance Limited, Titan Winners Fund Management Llp, Tc Sponsor & Services Llp and 2 more
|
Director | 14 Oct 2020 | 5 Years 9 Months | As last reported |
Financials of Piramal Enterprises Limited FY 2024 filings available
Piramal Enterprises Limited reported revenue of ₹10,020 Cr (up 12.16% YoY) for FY 2024.
| Metrics | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹10,020 Cr | ₹8,934.3 Cr | ₹13,993 Cr | ₹12,809 Cr | ₹13,068 Cr |
| Interest Earned | ₹7,313.89 Cr | ₹7,798.62 Cr | - | - | - |
| Other Income | ₹158.09 Cr | ₹152.44 Cr | ₹720.11 Cr | ₹363.64 Cr | ₹491.11 Cr |
| Total Income | ₹10,178 Cr | ₹9,086.74 Cr | ₹14,713 Cr | ₹13,173 Cr | ₹13,559 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹934.05 Cr | ₹1,412.2 Cr | ₹1,377.19 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹1,603.46 Cr | ₹664.69 Cr | ₹473.45 Cr |
| Changes in Inventories | ₹0 | ₹0 | -₹6.52 Cr | -₹155.3 Cr | -₹173.82 Cr |
| Employee Benefit Expense | ₹1,350.03 Cr | ₹930.05 Cr | ₹2,135.01 Cr | ₹1,650.47 Cr | ₹1,610.2 Cr |
| Finance Costs | ₹4,343.91 Cr | ₹3,994.32 Cr | ₹4,479.87 Cr | ₹4,208.53 Cr | ₹5,320.62 Cr |
| Depreciation & Amortisation | ₹828.96 Cr | ₹122.88 Cr | ₹665.78 Cr | ₹560.88 Cr | ₹520.3 Cr |
| Other Expenses | ₹1,533.27 Cr | ₹1,161.91 Cr | ₹2,877.08 Cr | ₹1,773.04 Cr | ₹3,513.9 Cr |
| Total Expenses | ₹11,524 Cr | ₹11,551 Cr | ₹12,689 Cr | ₹10,115 Cr | ₹12,642 Cr |
| Profit Before Exceptional Items & Tax | -₹1,345.54 Cr | -₹2,464.34 Cr | ₹2,024.68 Cr | ₹3,058.48 Cr | ₹917.56 Cr |
| Exceptional Items | -₹2,086.59 Cr | ₹8,066.26 Cr | -₹168 Cr | ₹58.86 Cr | ₹0 |
| Profit Before Tax | -₹3,432.13 Cr | ₹5,601.92 Cr | ₹1,856.68 Cr | ₹3,117.34 Cr | ₹917.56 Cr |
| Total Tax Expense | -₹1,594.87 Cr | -₹3,978.05 Cr | ₹510.79 Cr | ₹2,042.91 Cr | ₹1,960.43 Cr |
| Net Profit | -₹1,683.53 Cr | ₹9,968.58 Cr | ₹1,998.77 Cr | ₹1,412.86 Cr | ₹21.14 Cr |
| attributable to Owners | ₹0 | ₹9,968.58 Cr | ₹1,923.11 Cr | ₹1,332.34 Cr | ₹24.03 Cr |
| attributable to NCI | ₹0 | ₹0 | ₹75.66 Cr | ₹80.52 Cr | -₹2.89 Cr |
| Other Comprehensive Income | ₹76.52 Cr | ₹131.21 Cr | ₹72.94 Cr | ₹386.85 Cr | -₹953.28 Cr |
| Total Comprehensive Income | -₹1,607.01 Cr | ₹10,100 Cr | ₹2,071.71 Cr | ₹1,799.71 Cr | -₹932.14 Cr |
| EBITDA (computed) | ₹3,827.33 Cr | ₹1,652.86 Cr | ₹7,170.33 Cr | ₹7,827.89 Cr | ₹6,758.48 Cr |
| Basic EPS | ₹-72.82 | ₹417.68 | ₹80.70 | ₹56.19 | ₹-26.25 |
| Diluted EPS | ₹-72.82 | ₹416.30 | ₹80.40 | ₹55.68 | ₹-26.25 |
| Metrics | FY 2024 | FY 2023 |
|---|---|---|
| Total Assets | ₹82,605 Cr | ₹83,752 Cr |
| Property, Plant & Equipment | ₹402.06 Cr | ₹336.2 Cr |
| Inventories | ₹0 | ₹0 |
| Cash & Equivalents | ₹3,273.53 Cr | ₹3,729 Cr |
| Equity (Net Worth) | ₹26,557 Cr | ₹31,059 Cr |
| Equity Share Capital | ₹44.93 Cr | ₹47.73 Cr |
| Metrics | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Operating Cash Flow | ₹26.43 Cr | ₹1,359.34 Cr | ₹9,916.18 Cr |
| Investing Cash Flow | -₹1,871.6 Cr | -₹351.24 Cr | -₹2,226.18 Cr |
| Financing Cash Flow | ₹1,389.7 Cr | -₹3,563.16 Cr | -₹6,987.97 Cr |
| Capital Expenditure | ₹1,269.69 Cr | ₹202.6 Cr | ₹958.42 Cr |
| Free Cash Flow (computed) | -₹1,243.26 Cr | ₹1,156.74 Cr | ₹8,957.76 Cr |
| Dividends Paid | ₹739.86 Cr | ₹787.59 Cr | ₹797.59 Cr |
| Net Change in Cash | -₹455.47 Cr | -₹2,555.06 Cr | ₹699.98 Cr |
| Segment · FY 2022 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Financial services | ₹7,292.66 Cr | ₹1,477.93 Cr | - | - |
| Pharmaceuticals | ₹6,700.64 Cr | ₹1,191.31 Cr | - | - |
| Metrics | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹3,734.3 Cr | ₹4,785.22 Cr | ₹2,225.68 Cr | ₹1,824.7 Cr | ₹4,219.19 Cr |
| Interest Earned | ₹1,735.53 Cr | ₹1,736.47 Cr | - | - | - |
| Other Income | ₹90.91 Cr | ₹51.91 Cr | ₹467.5 Cr | ₹95.76 Cr | ₹699.06 Cr |
| Total Income | ₹3,825.21 Cr | ₹4,837.13 Cr | ₹2,693.18 Cr | ₹1,920.46 Cr | ₹4,918.25 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹294.23 Cr | ₹332.74 Cr | ₹878.18 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹774.39 Cr | ₹159.52 Cr | ₹75.92 Cr |
| Changes in Inventories | ₹0 | ₹0 | -₹96.46 Cr | -₹53.32 Cr | -₹10.73 Cr |
| Employee Benefit Expense | ₹153.91 Cr | ₹83.86 Cr | ₹120.64 Cr | ₹81.99 Cr | ₹463.15 Cr |
| Finance Costs | ₹745.16 Cr | ₹711.77 Cr | ₹761.16 Cr | ₹1,068.77 Cr | ₹1,710.06 Cr |
| Depreciation & Amortisation | ₹672.63 Cr | ₹23 Cr | ₹22.92 Cr | ₹32.82 Cr | ₹175.46 Cr |
| Other Expenses | ₹249.91 Cr | ₹227 Cr | ₹164.99 Cr | ₹108.79 Cr | ₹1,086.37 Cr |
| Total Expenses | ₹2,923.47 Cr | ₹2,438.45 Cr | ₹2,041.87 Cr | ₹1,731.31 Cr | ₹4,378.41 Cr |
| Profit Before Exceptional Items & Tax | ₹901.74 Cr | ₹2,398.68 Cr | ₹651.31 Cr | ₹189.15 Cr | ₹539.84 Cr |
| Exceptional Items | -₹365 Cr | ₹11,912 Cr | -₹10.2 Cr | -₹258.35 Cr | ₹0 |
| Profit Before Tax | ₹536.74 Cr | ₹14,311 Cr | ₹641.11 Cr | -₹69.2 Cr | ₹539.84 Cr |
| Total Tax Expense | ₹62.69 Cr | -₹22.4 Cr | ₹68.83 Cr | ₹51.02 Cr | ₹394.99 Cr |
| Net Profit | ₹474.05 Cr | ₹14,333 Cr | ₹572.28 Cr | ₹39.9 Cr | ₹144.85 Cr |
| Other Comprehensive Income | -₹21.99 Cr | ₹145.57 Cr | ₹28.13 Cr | ₹380.55 Cr | -₹1,379.83 Cr |
| Total Comprehensive Income | ₹452.06 Cr | ₹14,479 Cr | ₹600.41 Cr | ₹420.45 Cr | -₹1,234.98 Cr |
| EBITDA (computed) | ₹2,319.53 Cr | ₹3,133.45 Cr | ₹1,435.39 Cr | ₹1,290.74 Cr | ₹2,425.36 Cr |
| Basic EPS | ₹20.50 | ₹600.57 | ₹24.02 | ₹-5.07 | ₹6.87 |
| Diluted EPS | ₹20.35 | ₹598.58 | ₹23.93 | ₹-5.07 | ₹6.84 |
| Metrics | FY 2024 | FY 2023 |
|---|---|---|
| Total Assets | ₹29,806 Cr | ₹33,104 Cr |
| Property, Plant & Equipment | ₹12.71 Cr | ₹22.65 Cr |
| Inventories | ₹0 | ₹0 |
| Cash & Equivalents | ₹1,201.86 Cr | ₹1,678.22 Cr |
| Equity (Net Worth) | ₹21,592 Cr | ₹24,034 Cr |
| Equity Share Capital | ₹44.93 Cr | ₹47.73 Cr |
| Metrics | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Operating Cash Flow | ₹3,091.45 Cr | ₹916.92 Cr | ₹1,255.85 Cr |
| Investing Cash Flow | ₹166.89 Cr | -₹37.31 Cr | ₹382.09 Cr |
| Financing Cash Flow | -₹3,734.7 Cr | -₹603.5 Cr | -₹1,555.99 Cr |
| Capital Expenditure | ₹50.66 Cr | ₹8.71 Cr | ₹23.99 Cr |
| Free Cash Flow (computed) | ₹3,040.79 Cr | ₹908.21 Cr | ₹1,231.86 Cr |
| Dividends Paid | ₹739.86 Cr | ₹787.59 Cr | ₹787.59 Cr |
| Net Change in Cash | -₹476.36 Cr | ₹276.11 Cr | ₹81.95 Cr |
Ownership and Shareholding of Piramal Enterprises Limited
Shareholding and ownership data for Piramal Enterprises Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Piramal Enterprises Limited
Piramal Enterprises Limited has 19 subsidiary companies and 7 associated companies. This group structure data is as of FY 2022. The corporate group structure reflects Piramal Enterprises Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Piramal Capital & Housing Finance Limited | L65910MH1984PLC032639 | - |
| Hemmo Pharmaceuticals Private Limited | U17100MH1979PTC021857 | - |
| Convergence Chemicals Private Limited | U24100MH2014PTC373507 | - |
| Piramal Pharma Limited | U24297MH2020PLC338592 | - |
| Pel Finhold Private Limited | U65190MH2014PTC257414 | - |
| Piramal Investment Advisory Services Private Limited | U65191MH2013PTC244440 | - |
Showing major subsidiaries. Total: 19.
Charges & Borrowings of Piramal Enterprises Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Oct 2024 | Others | ₹600 Cr | Satisfied |
| 26 Feb 2024 | Others | ₹750 Cr | Satisfied |
| 03 Jan 2024 | Idbi Trusteeship Services Limited | ₹150 Cr | Satisfied |
| 27 Oct 2023 | Others | ₹800 Cr | Satisfied |
| 26 Oct 2023 | Others | ₹375 Cr | Satisfied |
Total charge records: 96 View all charges
Employees and EPFO Compliance at Piramal Enterprises Limited
Piramal Enterprises Limited has a workforce of 241 employees as of Oct 08, 2025.
Employee and EPFO history for Piramal Enterprises Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Piramal Enterprises Limited
GST registrations and filing compliance for Piramal Enterprises Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Piramal Enterprises Limited
Credit ratings, litigation, and regulatory alerts for Piramal Enterprises Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Piramal Enterprises Limited
MSME payment history for Piramal Enterprises Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Piramal Enterprises Limited
Corporate group structure for Piramal Enterprises Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Piramal Enterprises Limited
MCA filings and documents for Piramal Enterprises Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Piramal Enterprises Limited
Recent News on Piramal Enterprises Limited
Frequently Asked Questions about Piramal Enterprises Limited
Piramal Enterprises Limited has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Piramal Enterprises Limited is a amalgamated public limited company in the financial services sector based in Mumbai, Maharashtra, India. It was incorporated on 26 April 1947 and is registered under CIN L24110MH1947PLC005719. Listed on BSE: 500302 and NSE: PEL. The company was amalgamated as per MCA records and no longer exists as a legal entity.
Piramal Enterprises Limited was incorporated on 26 April 1947. Registered with ROC Mumbai.
The current directors and KMP of Piramal Enterprises Limited are:
- Anand Ajay Piramal - Director
- Puneet Yadu Dalmia - Director
- Anjali Bansal - Director
- Rajiv Mehrishi - Director
- Gautam Bhailal Doshi - Director
- Kunal Bahl - Director
- Swati Ajay Piramal - Whole-Time Director
- Ajay Gopikisan Piramal - Whole-Time Director
- Nandini Ajay Piramal - Director
- Vijay Kantilal Shah - Director
- Shikha Sanjaya Sharma - Director
- Bipin Singh - Company Secretary
- Anita Marangoly George - Director
- Suhail Amin Nathani - Director
- Upma Goel - Cfo
- Asheet Lalit Mehta - Director
The CIN (Corporate Identification Number) of Piramal Enterprises Limited is L24110MH1947PLC005719. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The primary industry of Piramal Enterprises Limited is financial services. The company specifically operates in nbfc.